UroGen Pharma Ltd (URGN) — Net Asset Quality Index
UroGen Pharma Ltd (URGN) has a Net Asset Quality Index of -52.4% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $252.59 Million minus total liabilities of $384.99 Million yields net assets of $-132.40 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read total liabilities of UroGen Pharma Ltd for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
UroGen Pharma Ltd Net Asset Quality Index Over Time (2013–2025)
This chart shows how UroGen Pharma Ltd's Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of June 2026, the index stands at -52.4%, representing net assets of $-132.40 Million against total assets of $252.59 Million USD. For live market cap and overall valuation, see market cap of UroGen Pharma Ltd.
Annual Net Asset Quality Index for UroGen Pharma Ltd (2013–2025)
The table below presents the year-by-year Net Asset Quality Index for UroGen Pharma Ltd from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check URGN strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -52.6% | $-105.47 Million | $200.46 Million | $305.93 Million | ▼ -49.5 pp |
| 2024 | -3.1% | $-8.80 Million | $285.71 Million | $294.51 Million | ▲ +33.5 pp |
| 2023 | -36.6% | $-65.21 Million | $178.31 Million | $243.52 Million | ▲ +29.3 pp |
| 2022 | -65.9% | $-89.36 Million | $135.62 Million | $224.98 Million | ▼ -72.9 pp |
| 2021 | 7.0% | $8.41 Million | $119.75 Million | $111.33 Million | ▼ -72.0 pp |
| 2020 | 79.0% | $96.36 Million | $122.00 Million | $25.65 Million | ▼ -10.1 pp |
| 2019 | 89.1% | $180.30 Million | $202.39 Million | $22.09 Million | ▲ +2.1 pp |
| 2018 | 87.0% | $90.09 Million | $103.56 Million | $13.46 Million | ▼ -3.7 pp |
| 2017 | 90.7% | $68.52 Million | $75.55 Million | $7.04 Million | ▲ +20.0 pp |
| 2016 | 70.7% | $16.31 Million | $23.06 Million | $6.75 Million | ▼ -17.7 pp |
| 2015 | 88.5% | $17.15 Million | $19.39 Million | $2.24 Million | ▲ +8.9 pp |
| 2014 | 79.6% | $3.47 Million | $4.36 Million | $891.00K | ▼ -5.4 pp |
| 2013 | 85.0% | $2.74 Million | $3.23 Million | $484.00K | — |